NASDAQFinancialsBanks - RegionalSnapshot 2026-11-04
The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.
Next-FY EPS estimate change · 30 days
Matching fiscal periods, usable estimates and at least one analyst are required.
One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.
The calculation requires same-period, same-provider snapshots, positive EPS, at least one analyst and a baseline within three days of the requested lookback.
The EPS and P/E reference is not available for PKBK yet.
| Measure / period | Management expectations | Analyst expectations |
|---|
Management figures unavailable.
Current consensus figures unavailable.
Three published thesis conditions, with dated milestones shown separately.
| Key Factor | Why It Matters | Current Status | Break Condition | Latest Evidence |
|---|---|---|---|---|
Maintain quarterly dividend of $0.18 per share | Parke Bancorp keeps paying a steady dividend of $0.18 per share. | Intact | dividend per share falls below $0.18 in any quarter | Dividend per share: $0.20 per share FY2026-Q3; GAAP. Published target: >=0.18 USD per share per quarter. Target period is not explicitly aligned with this observation. Nov 4, 20260.2 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Compare these dated observations with the operating requirements above
Comparable estimate history is unavailable.
Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.
Compare required revenue and earningsMonthly analyst history is unavailable.
Recent actions · Oct 6–Nov 4 · 0 recorded
The evidence, the remaining questions, and what comes next
No recovery evidence is reported in the available driver assessments.
Next earnings date unavailable
Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.
Observed price history; separate from operating scenarios
The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.
This is a regional bank investment with a value tilt, rather than a turnaround story. The long-term thesis is intact, and recent financial performance is in the top half of its industry, though management execution and earnings quality are rated neutral.
PKBK is cheap versus peers, and the valuation signal is assessed with high confidence. The expectations gap is negative, which points to limited expectations relative to the model, while the priced-in assessment is tagged justified and fragility is low.
Near term, recent results show progress: gross loans and nine-month net income increased, and nonperforming loans declined. Expense discipline and credit quality are less clear, as nine-month expenses rose and the quarterly credit-loss provision increased. The near-term miss risk is described as low, but the smaller-cap profile and a trend of declining earnings surprises remain watch points.
The multi-year view depends in part on continued loan growth, expense control, and credit quality. A guidance cut on the next call would be a meaningful negative, while rate cuts from the current level could weigh on the Financials sector. Continued earnings strength and higher guidance from sector bellwethers would support sector momentum.
For the next 1 to 3 years, PKBK’s thesis rests on sustaining loan and earnings growth while containing expenses and credit risk. Recent performance supports the thesis, but the evidence is mixed on execution and confidence is medium. Not investment advice.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
| Earnings per share are expected to grow to at least $3.16 by the end of 2026. |
| Intact |
| EPS falls below $2.25 in FY25 or fails to reach $3.16 in FY26 |
Diluted EPS: $1.02 per share FY2026-Q3; GAAP. Published target: >=3.16 USD per share. Annual target cannot be compared with a quarterly or TTM observation. Nov 4, 20261.02 USD/share · source valueLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Continue share repurchase program up to 5% of shares annually | A supporting condition in Parke Bancorp, Inc.'s published investment case. The stated target is repurchase up to 5% of shares within 12 months. | Intact | no buyback activity or cancellation of program within 12 months | Direct metric needs a verified mapping The published measure or accounting basis is not supported by an exact source binding. Date unavailableLast status assessment Nov 4, 2026Compare required operating outcomesCompare scope, accounting basis and period before treating this evidence as progress against an annual requirement. |
Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.
Individual price-target observations are unavailable.
0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior
Oct 6, 2026–Nov 4, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.
3 of 3 published conditions remain under pressure or need verification. The next results need to address those conditions.
The dated weekly assessment and its assumptions are available in Read detailed Outlook.